Sodium Hypochlorite 0.005% Versus Placebo in the Treatment of Mild to Moderate Acne: A Double-Blind Randomized Controlled Trial

Background: Acne vulgaris is a common inflammatory disease of the pilosebaceous follicle that affects many teenagers and young people. There is an obvious need for topical treatments with good tolerability and efficacy for the management of acne lesions. Objective: This study determined the ther...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Azadeh Dorostkar, Mehdi Ghahartars, Mohammad Reza Namazi, Nafiseh Todarbary, Maryam Hadibarhaghtalab, Maryam Rezaee
Formato: article
Lenguaje:EN
Publicado: Mattioli1885 2021
Materias:
Acceso en línea:https://doaj.org/article/5b4381e201fb460d915dc2cbb8be3e2e
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:5b4381e201fb460d915dc2cbb8be3e2e
record_format dspace
spelling oai:doaj.org-article:5b4381e201fb460d915dc2cbb8be3e2e2021-11-17T08:27:54ZSodium Hypochlorite 0.005% Versus Placebo in the Treatment of Mild to Moderate Acne: A Double-Blind Randomized Controlled Trial 10.5826/dpc.1103a462160-9381https://doaj.org/article/5b4381e201fb460d915dc2cbb8be3e2e2021-05-01T00:00:00Zhttp://dpcj.org/index.php/dpc/article/view/1565https://doaj.org/toc/2160-9381 Background: Acne vulgaris is a common inflammatory disease of the pilosebaceous follicle that affects many teenagers and young people. There is an obvious need for topical treatments with good tolerability and efficacy for the management of acne lesions. Objective: This study determined the therapeutic efficacy of topical sodium hypochlorite solution (0.005%) in the treatment of mild to moderate acne lesions. Methods: This placebo-controlled randomized controlled trial compared 0.005% sodium hypochlorite to placebo administered topically on each side of the patients’ faces 3 times a day for 1 month. The numbers of papules and pustules were recorded at baseline, 1, 2 and 4 weeks after initiation. Results: The total number of papules and pustules decreased after topical application of sodium hypochlorite 0.005% for 1 month. Conclusions: Topical sodium hypochlorite solution (0.005%) can be effective in the treatment of mild to moderate acne, and its clinical efficacy was evaluated between the male and female groups and between the hormonal and non-hormonal ones. Trial registration: Our study was registered in the Iranian Registry of Clinical Trials (IRCT) with the code number IRCT20200701047976N1. Azadeh DorostkarMehdi GhahartarsMohammad Reza NamaziNafiseh TodarbaryMaryam HadibarhaghtalabMaryam RezaeeMattioli1885articletopicalsodium hypoclorite 0.005%acnetreatmentDermatologyRL1-803ENDermatology Practical & Conceptual (2021)
institution DOAJ
collection DOAJ
language EN
topic topical
sodium hypoclorite 0.005%
acne
treatment
Dermatology
RL1-803
spellingShingle topical
sodium hypoclorite 0.005%
acne
treatment
Dermatology
RL1-803
Azadeh Dorostkar
Mehdi Ghahartars
Mohammad Reza Namazi
Nafiseh Todarbary
Maryam Hadibarhaghtalab
Maryam Rezaee
Sodium Hypochlorite 0.005% Versus Placebo in the Treatment of Mild to Moderate Acne: A Double-Blind Randomized Controlled Trial
description Background: Acne vulgaris is a common inflammatory disease of the pilosebaceous follicle that affects many teenagers and young people. There is an obvious need for topical treatments with good tolerability and efficacy for the management of acne lesions. Objective: This study determined the therapeutic efficacy of topical sodium hypochlorite solution (0.005%) in the treatment of mild to moderate acne lesions. Methods: This placebo-controlled randomized controlled trial compared 0.005% sodium hypochlorite to placebo administered topically on each side of the patients’ faces 3 times a day for 1 month. The numbers of papules and pustules were recorded at baseline, 1, 2 and 4 weeks after initiation. Results: The total number of papules and pustules decreased after topical application of sodium hypochlorite 0.005% for 1 month. Conclusions: Topical sodium hypochlorite solution (0.005%) can be effective in the treatment of mild to moderate acne, and its clinical efficacy was evaluated between the male and female groups and between the hormonal and non-hormonal ones. Trial registration: Our study was registered in the Iranian Registry of Clinical Trials (IRCT) with the code number IRCT20200701047976N1.
format article
author Azadeh Dorostkar
Mehdi Ghahartars
Mohammad Reza Namazi
Nafiseh Todarbary
Maryam Hadibarhaghtalab
Maryam Rezaee
author_facet Azadeh Dorostkar
Mehdi Ghahartars
Mohammad Reza Namazi
Nafiseh Todarbary
Maryam Hadibarhaghtalab
Maryam Rezaee
author_sort Azadeh Dorostkar
title Sodium Hypochlorite 0.005% Versus Placebo in the Treatment of Mild to Moderate Acne: A Double-Blind Randomized Controlled Trial
title_short Sodium Hypochlorite 0.005% Versus Placebo in the Treatment of Mild to Moderate Acne: A Double-Blind Randomized Controlled Trial
title_full Sodium Hypochlorite 0.005% Versus Placebo in the Treatment of Mild to Moderate Acne: A Double-Blind Randomized Controlled Trial
title_fullStr Sodium Hypochlorite 0.005% Versus Placebo in the Treatment of Mild to Moderate Acne: A Double-Blind Randomized Controlled Trial
title_full_unstemmed Sodium Hypochlorite 0.005% Versus Placebo in the Treatment of Mild to Moderate Acne: A Double-Blind Randomized Controlled Trial
title_sort sodium hypochlorite 0.005% versus placebo in the treatment of mild to moderate acne: a double-blind randomized controlled trial
publisher Mattioli1885
publishDate 2021
url https://doaj.org/article/5b4381e201fb460d915dc2cbb8be3e2e
work_keys_str_mv AT azadehdorostkar sodiumhypochlorite0005versusplacebointhetreatmentofmildtomoderateacneadoubleblindrandomizedcontrolledtrial
AT mehdighahartars sodiumhypochlorite0005versusplacebointhetreatmentofmildtomoderateacneadoubleblindrandomizedcontrolledtrial
AT mohammadrezanamazi sodiumhypochlorite0005versusplacebointhetreatmentofmildtomoderateacneadoubleblindrandomizedcontrolledtrial
AT nafisehtodarbary sodiumhypochlorite0005versusplacebointhetreatmentofmildtomoderateacneadoubleblindrandomizedcontrolledtrial
AT maryamhadibarhaghtalab sodiumhypochlorite0005versusplacebointhetreatmentofmildtomoderateacneadoubleblindrandomizedcontrolledtrial
AT maryamrezaee sodiumhypochlorite0005versusplacebointhetreatmentofmildtomoderateacneadoubleblindrandomizedcontrolledtrial
_version_ 1718425799554498560